2516-96-3O=C(O)c1cc([N+](=O)[O-])ccc1ClQUEKGYQTRJVEQC-UHFFFAOYSA-Nstructure in first source
2516-96-3DTXSID9062485Danger
H302 (71.4%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P272, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 56 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Benzoic acid, 2-chloro-5-nitro-
Status: Active Update: 14-06-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/11817
2-Chloro-5-nitrobenzoic acid: Does not have an individual approval but may be used under an appropriate group standard
Uses2-Chloro-5-nitrobenzoic Acid is used in the synthesis of sesquiterpenoids as potential antibacterial compounds. Also used in the synthesis of substituted phenyl oxazoles as novel LSD1 inhibitors with antiproliferative activity. In addition it’s used to synthesize cathespin L inhibitors.
General Description2-Chloro-5-nitrobenzoic acid undergoes microwave-assisted, regioselective amination reaction with aliphatic and aromatic amines to yield N-substituted 5-nitroanthranilic acid derivatives. It acts as ligand and forms a red luminescent one dimensional coordination polymer with Eu(III).
Loading…
CHEMBL2179897